Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V (openhouse Model) 2026-03-01
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph 8 Sgb V For Various Active Ingredients/s/combinations With The Possibility Of Concluding At Any Time Within The Framework Of The So-called Open House Procedure 2026-03-05
Germany Open Framework Agreement On Drug Discounts In Accordance With Section 130a Paragraph 8 Sgb V With The Possibility Of Joining At Any Time, So-called Approval Model 202403 2026-03-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredients Sofosbuvir And Velpatasvir, Atc J05ap55 For The Period May 1, 2024 April 30, 2026 2026-03-05
Germany Open House Drug Discount Agreements Atovaquone, Atc P01ax06 2026-03-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Trientine, Atc A16ax12 For The Period May 1st, 2024 April 30th, 2026 2026-03-05
Germany Open House Drug Discount Agreements Levothyroxine Sodium, Atc H03aa01 2026-03-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Molsidomin, Atc C01dx12 For The Period May 1st, 2024 April 30th, 2026 2026-03-05
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Megestrol, Atc L02ab01 For The Period May 1st, 2024 April 30th, 2026 2026-03-05
Germany Open House Drug Discount Agreements Eptinezumab, Atc N02cd05 2026-03-05
Whats app